title: Impact of metabolic syndrome in acute myocardial infarction at hospital.
abstract: The study was aimed to find out the impact of metabolic syndrome in patients with acute myocardial infarction during hospital stay. This prospective study was carried out in coronary care unit, Mymensingh Medical College Hospital from August 2009 to May 2010. Patients were followed up for minimum 3 days to maximum 6 days after admission. Variables of this study were age, sex, smoking, anterior AMI, inferior AMI, Non STEMI, hyperglycemia, low high density lipoprotein (HDL), raised blood pressure, high triglyceride (TG), waist circumference, recurrent non fatal MI, heart failure (Killip class), arrhythmia (VT, VF), ejection fraction (EF), family history of cardiovascular (CV) risk factors. Considering inclusion and exclusion criteria total 100 patients were included and divided into two groups, Group A - Acute Myocardial Infarction (AMI) with Metabolic Syndrome (MS) and Group B - Acute Myocardial Infarction (AMI) without Metabolic Syndrome (MS). Investigations included ECG, FBS, fasting lipid profile, cardiac enzyme (troponin I) and echocardiography (2D & M mode). The data were analyzed by computer software SPSS version 12. Chi-square test, t test, ANOVA test was used as test of significance. Among the study population (n=100), female were 12.0%. Mean age of study population was 53.3±10.6 years vs. 47.5±11.3 years. Distribution of metabolic syndrome components in study population, High TG (?150mg/dl) was more prevalent (81.1% vs. 25.8%). Heart failure (Killip class) was significantly more in metabolic syndrome patients than those without metabolic syndrome (46.0 % vs. 20%). LV ejection fraction also lowers in metabolic syndrome patients (46.76±8.34 vs. 50.45±7.50) with MI. Among the components of metabolic syndrome, hyperglycemia had strongest association for development of heart failure (OR 3.05; 95% CI 0.80-12.14).
authors.affiliation: Trishal Health Complex, Mymensingh, Bangladesh.
authors.forename: M S
authors.initials: MS
authors.lastname: Islam
authors.forename: M A
authors.initials: MA
authors.lastname: Bari
authors.forename: G K
authors.initials: GK
authors.lastname: Paul
authors.forename: M Z
authors.initials: MZ
authors.lastname: Islam
authors.forename: M Z
authors.initials: MZ
authors.lastname: Rahman
authors.forename: M
authors.initials: M
authors.lastname: Hoshneara
authors.forename: M A
authors.initials: MA
authors.lastname: Karim
authors.forename: M N
authors.initials: MN
authors.lastname: Nabi
authors.forename: H
authors.initials: H
authors.lastname: Pandit
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D016009:Chi-Square Distribution; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure / Q000401:mortality / Q000503:physiopathology*; D017052:Hospital Mortality; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D024821:Metabolic Syndrome / Q000401:mortality / Q000503:physiopathology*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000503:physiopathology*; D011446:Prospective Studies; D012307:Risk Factors; D019210:Troponin I / Q000097:blood
chemical_list: D008055:Lipids; D019210:Troponin I